基本信息
浏览量:12
职业迁徙
个人简介
“Mike has been a driving force in the sequencing industry for three
decades, and we are honored that he has agreed to take a more active
role with PacBio,” said Hugh Martin. “We look forward to being able to
draw more heavily on his expertise, experience and relationships with
customers in the life science tools market.”
Dr. Hunkapiller commented: “I have spent much of my career on the
leading edge of sequencing technology and I believe PacBio’s single
molecule, real-time technology will disrupt the sequencing market. I am
delighted that Hugh and the Board asked me to take on this newly created
role and look forward to devoting more time to advising the company on
how to accelerate adoption of their products in important applications.”
A renowned scientist, entrepreneur and life science industry executive,
Dr. Hunkapiller spent 21 years at Applied Biosystems (ABI), which he
co-founded and helped grow from startup to nearly $2 billion in annual
revenues supplying instrument and reagent systems for life science
research. He was also a founder of ABI’s sister company Celera Genomics
and Senior Vice President of Applera Corp. (their parent company). Prior
to joining ABI, Mike was a senior research fellow in the Division of
Biology at the California Institute of Technology.
研究兴趣
论文共 42 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
SCIENCEno. 6588 (2021): 44-+
Jeong-Sun Seo,Arang Rhie, Junsoo Kim,Sangjin Lee, Min-Hwan Sohn,Chang-Uk Kim,Alex Hastie,Han Cao,Ji-Young Yun,Jihye Kim, Junho Kuk, Gun Hwa Park,
mag(1990)
引用430浏览0引用
430
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn